These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9737881)
1. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras. Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881 [TBL] [Abstract][Full Text] [Related]
2. Domains of interaction between alpha interferon and its receptor components. Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753 [TBL] [Abstract][Full Text] [Related]
3. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons. Langer JA; Yang J; Carmillo P; Ling LE FEBS Lett; 1998 Jan; 421(2):131-5. PubMed ID: 9468293 [TBL] [Abstract][Full Text] [Related]
4. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists. Pan M; Kalie E; Scaglione BJ; Raveche ES; Schreiber G; Langer JA Biochemistry; 2008 Nov; 47(46):12018-27. PubMed ID: 18937499 [TBL] [Abstract][Full Text] [Related]
5. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding. Cutrone EC; Langer JA J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538 [TBL] [Abstract][Full Text] [Related]
6. Homology model of human interferon-alpha 8 and its receptor complex. Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464 [TBL] [Abstract][Full Text] [Related]
7. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939 [TBL] [Abstract][Full Text] [Related]
8. Evidence for glycosphingolipid modification of the type 1 IFN receptor. Ghislain J; Lingwood CA; Fish EN J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586 [TBL] [Abstract][Full Text] [Related]
9. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669 [TBL] [Abstract][Full Text] [Related]
10. Contributions of cloned type I interferon receptor subunits to differential ligand binding. Cutrone EC; Langer JA FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063 [TBL] [Abstract][Full Text] [Related]
11. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit. Kumaran J; Colamonici OR; Fish EN J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076 [TBL] [Abstract][Full Text] [Related]
12. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons. Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298 [TBL] [Abstract][Full Text] [Related]
13. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680 [TBL] [Abstract][Full Text] [Related]
14. [Anti-viral proteins: from interferon alpha to its receptor]. Chieux V; Hober D; Chehadeh W; Wattr P Ann Biol Clin (Paris); 1999 May; 57(3):283-90. PubMed ID: 10377478 [TBL] [Abstract][Full Text] [Related]
15. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor. Chill JH; Quadt SR; Anglister J Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740 [TBL] [Abstract][Full Text] [Related]
16. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. Piehler J; Schreiber G J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041 [TBL] [Abstract][Full Text] [Related]
17. Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis. Goldman LA; Zafari M; Cutrone EC; Dang A; Brickelmeier M; Runkel L; Benjamin CD; Ling LE; Langer JA J Interferon Cytokine Res; 1999 Jan; 19(1):15-26. PubMed ID: 10048764 [TBL] [Abstract][Full Text] [Related]
18. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007 [TBL] [Abstract][Full Text] [Related]
19. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence. Subramaniam PS; Johnson HM FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821 [TBL] [Abstract][Full Text] [Related]
20. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. Russell-Harde D; Wagner TC; Perez HD; Croze E Biochem Biophys Res Commun; 1999 Feb; 255(2):539-44. PubMed ID: 10049744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]